Trial Outcomes & Findings for Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section (NCT NCT03330119)

NCT ID: NCT03330119

Last Updated: 2021-03-02

Results Overview

total narcotic utilization measured with Morphine Milligram Equivalent (MME) The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome.

Recruitment status

TERMINATED

Study phase

PHASE3

Target enrollment

1494 participants

Primary outcome timeframe

From time of consent until hospital discharge (3 days)

Results posted on

2021-03-02

Participant Flow

Participant milestones

Participant milestones
Measure
Alternate Management
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
Control
The regular Lankenau cesarean section order set. Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
Overall Study
STARTED
641
853
Overall Study
COMPLETED
475
571
Overall Study
NOT COMPLETED
166
282

Reasons for withdrawal

Reasons for withdrawal
Measure
Alternate Management
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
Control
The regular Lankenau cesarean section order set. Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
Overall Study
Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups
166
282

Baseline Characteristics

Baseline Measures were only recorded and analyzed for the participants who completed the study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Alternate Management
n=475 Participants
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
Control
n=571 Participants
The regular Lankenau cesarean section order set. Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
Total
n=1046 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
475 Participants
n=99 Participants
571 Participants
n=107 Participants
1046 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Continuous
32.4 years
STANDARD_DEVIATION 5.0 • n=99 Participants
31.9 years
STANDARD_DEVIATION 4.7 • n=107 Participants
32.1 years
STANDARD_DEVIATION 4.9 • n=206 Participants
Sex: Female, Male
Female
475 Participants
n=99 Participants
571 Participants
n=107 Participants
1046 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
4 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
3 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
7 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
Asian
14 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
34 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
48 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
0 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
0 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
Black or African American
142 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
141 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
283 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
White
302 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
370 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
672 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
More than one race
3 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
10 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
13 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Race (NIH/OMB)
Unknown or Not Reported
10 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
13 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
23 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
Region of Enrollment
United States
475 participants
n=99 Participants
571 participants
n=107 Participants
1046 participants
n=206 Participants

PRIMARY outcome

Timeframe: From time of consent until hospital discharge (3 days)

total narcotic utilization measured with Morphine Milligram Equivalent (MME) The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome.

Outcome measures

Outcome measures
Measure
Alternate Management
n=476 Participants
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
Control
n=641 Participants
The regular Lankenau cesarean section order set. Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
Narcotic Utilization
33.3 MME
Standard Deviation 52.4
47.2 MME
Standard Deviation 60.4

Adverse Events

Alternate Management

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Norman Brest

Main Line Health System

Phone: 484-476-2325

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place